In Vivo Activation of Rat Aortic Platelet-Derived Growth Factor and Epidermal Growth Factor Receptors by Angiotensin II and Hypertension
Authors:
- 1 December 2000
- journal article
- other
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 20 (12) , 2539-2545
Abstract
—It is unclear whether the previous in vitro evidence of a link between angiotensin II (Ang II) and growth factor receptors can apply to the in vivo situation. In this study, we examined vascular platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) receptor activation in stroke-prone spontaneously hypertensive rats (SHRSP) and the role of Ang II. Tyrosyl phosphorylation of the growth factor receptors was determined by Western blot analysis coupled with immunoprecipitation. Tyrosyl phosphorylation of the aortic PDGF β-receptor, but not the EGF receptor, was chronically increased in SHRSP with hypertension, compared with normotensive rats, being accompanied by increased extracellular signal–regulated kinase (ERK) activity. Treatment of SHRSP with ACE inhibitors (perindopril or enalapril) significantly reduced aortic PDGF β-receptor tyrosyl phosphorylation and ERK activity, whereas treatment with hydralazine failed to reduce these activities. Therefore, these aortic changes in SHRSP were mediated by Ang II in response to vascular ACE. Ang II was infused into rats to examine the effects on aortic growth factor receptors. Chronic Ang II infusion, via the angiotensin type 1 receptor, significantly increased activation of the aortic PDGF β-receptor but not the EGF receptor. Thus, the aortic PDGF β-receptor, activated by ACE-mediated Ang II, seems to be responsible for vascular remodeling in hypertensive rats.Keywords
This publication has 29 references indexed in Scilit:
- ANGIOTENSIN‐CONVERTING ENZYME INHIBITORS AND ATHEROSCLEROSIS: RELEVANCE OF ANIMAL MODELS TO HUMAN DISEASEClinical and Experimental Pharmacology and Physiology, 1996
- Identification of an Essential Signaling Cascade for Mitogen-activated Protein Kinase Activation by Angiotensin II in Cultured Rat Vascular Smooth Muscle CellsJournal of Biological Chemistry, 1996
- Blood pressure regulates platelet-derived growth factor A-chain gene expression in vascular smooth muscle cells in vivo. An autocrine mechanism promoting hypertensive vascular hypertrophy.Journal of Clinical Investigation, 1995
- Effect of Low-Dose Treatment with Perindopril on Cardiac Function in Stroke-Prone Spontaneously Hypertensive RatsJournal of Cardiovascular Pharmacology, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Increased EGF binding and EGFR mRNA expression in rat aorta with chronic administration of pressor angiotensin IIBiochemical Medicine and Metabolic Biology, 1992
- Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty.Journal of Clinical Investigation, 1992
- Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia.Hypertension, 1991
- Hypertension-induced changes of platelet-derived growth factor receptor expression in rat aorta and heart.Hypertension, 1991
- Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular InjuryScience, 1989